Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu-Mei Tan

Showing results (11-20 of 75) with videos related to

Pageof 8
Sort By:
Frontiers in Pharmacology|December 6, 2014
Analysis of biomarker utility using a PBPK/PD model for carbarylMartin B Phillips, Miyoung Yoon, Bruce Young, et al.
Bioinformation|August 10, 2013
PROcEED: Probabilistic reverse dosimetry approaches for estimating exposure distributionsChristopher M Grulke, Kathleen Holm, Michael-Rock Goldsmith, et al.
Regulatory Toxicology and Pharmacology : RTP|September 4, 2017
Investigating the state of physiologically based kinetic modelling practices and challenges associated with gaining regulatory acceptance of model applicationsAlicia Paini, Jeremy A Leonard, Tomas Kliment, et al.
Environmental Science. Processes & Impacts|February 22, 2018
Refining the aggregate exposure pathwayYu-Mei Tan, Jeremy A Leonard, Stephen Edwards, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|February 1, 2018
Challenges Associated With Applying Physiologically Based Pharmacokinetic Modeling for Public Health Decision-MakingYu-Mei Tan, Rachel R Worley, Jeremy A Leonard, et al.
The Science of the Total Environment|September 13, 2011
A biomonitoring framework to support exposure and risk assessmentsJon R Sobus, Yu-Mei Tan, Joachim D Pleil, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|June 14, 2003
Biologically motivated computational modeling of chloroform cytolethality and regenerative cellular proliferationYu-Mei Tan, Byron E Butterworth, Michael L Gargas, et al.
Toxicology and Applied Pharmacology|July 1, 2008
Quantitative interpretation of human biomonitoring dataHarvey J Clewell, Yu Mei Tan, Jerry L Campbell, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|February 12, 2016
Estimating Margin of Exposure to Thyroid Peroxidase Inhibitors Using High-Throughput in vitro Data, High-Throughput Exposure Modeling, and Physiologically Based Pharmacokinetic/Pharmacodynamic ModelingJeremy A Leonard, Yu-Mei Tan, Mary Gilbert, et al.
Environment International|August 5, 2014
Changes in epidemiologic associations with different exposure metrics: a case study of phthalate exposure associations with body mass index and waist circumferenceKrista Christensen, Jon Sobus, Martin Phillips, et al.
Pageof 8

Showing results (11-20 of 75) with videos related to

Sort By:
Pageof 8
Frontiers in Pharmacology|December 6, 2014
Analysis of biomarker utility using a PBPK/PD model for carbarylMartin B Phillips, Miyoung Yoon, Bruce Young, et al.
Bioinformation|August 10, 2013
PROcEED: Probabilistic reverse dosimetry approaches for estimating exposure distributionsChristopher M Grulke, Kathleen Holm, Michael-Rock Goldsmith, et al.
Regulatory Toxicology and Pharmacology : RTP|September 4, 2017
Investigating the state of physiologically based kinetic modelling practices and challenges associated with gaining regulatory acceptance of model applicationsAlicia Paini, Jeremy A Leonard, Tomas Kliment, et al.
Environmental Science. Processes & Impacts|February 22, 2018
Refining the aggregate exposure pathwayYu-Mei Tan, Jeremy A Leonard, Stephen Edwards, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|February 1, 2018
Challenges Associated With Applying Physiologically Based Pharmacokinetic Modeling for Public Health Decision-MakingYu-Mei Tan, Rachel R Worley, Jeremy A Leonard, et al.
The Science of the Total Environment|September 13, 2011
A biomonitoring framework to support exposure and risk assessmentsJon R Sobus, Yu-Mei Tan, Joachim D Pleil, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|June 14, 2003
Biologically motivated computational modeling of chloroform cytolethality and regenerative cellular proliferationYu-Mei Tan, Byron E Butterworth, Michael L Gargas, et al.
Toxicology and Applied Pharmacology|July 1, 2008
Quantitative interpretation of human biomonitoring dataHarvey J Clewell, Yu Mei Tan, Jerry L Campbell, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|February 12, 2016
Estimating Margin of Exposure to Thyroid Peroxidase Inhibitors Using High-Throughput in vitro Data, High-Throughput Exposure Modeling, and Physiologically Based Pharmacokinetic/Pharmacodynamic ModelingJeremy A Leonard, Yu-Mei Tan, Mary Gilbert, et al.
Environment International|August 5, 2014
Changes in epidemiologic associations with different exposure metrics: a case study of phthalate exposure associations with body mass index and waist circumferenceKrista Christensen, Jon Sobus, Martin Phillips, et al.
Pageof 8